PIM Kinase
As a Phase I clinical trial, this study will firstly test the safety of this new drug.
For more information about this trial and eligibility criteria visit the US National Institutes of Health.
As a Phase I clinical trial, this study will firstly test the safety of this new drug.
For more information about this trial and eligibility criteria visit the US National Institutes of Health.
Everyman is the UK's leading prostate and testicular cancer campaign – run by The Institute of Cancer Research.
A Charity, Not for Profit. Company Limited by Guarantee. Registered in England No. 534147.
